ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Regenacy Pharmaceuticals Announces Patent Issuance for Ricolinostat
americanpharmaceuticalreview
August 20, 2018Regenacy Pharmaceuticals announced the issuance of U.S. Patent No. 10,040,769 covering the use of ricolinostat (ACY-1215) for the treatment of diabetic peripheral neuropathy (DPN). Ricolinostat is an oral, selective inhibitor of the microtubule modifying
Pharma Sources Insight January 2025
